Bexagliflozin clinical trials
Also written EGT0001442 and EGT0001474.
How each study uses Bexagliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Bexagliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Jan 2023 · BRENZAVVY · NDA 214373 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2016 (5)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 3
Theracos (15) · Baylor Research Institute (1) · University of Virginia (1) · Yale University (1) · Newsoara Biopharma Co., Ltd. (1)
Often tested with
Tested in the same studies.
Glimepiride (2) · Sitagliptin (2) · Metformin (1) · Exenatide (1) · Finerenone (1) · Semaglutide (1) · Benazepril (1) · Captopril (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
- One of SGLT2 inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Bexagliflozin.
- Sep 2027Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA StudyPhase 4 · Yale University
- Oct 2027Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)Phase 1 · University of Virginia
Studies
Open first, then newest update. How each study uses Bexagliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 19
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as BrenzavvyHow we know
- Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)RecruitingPhase 1University of VirginiaNCT06600178Written as Brenzavvy (bexagliflozin), 20 mg Oral TabletHow we know
- Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA StudyRecruitingPhase 4Yale UniversityNCT05612594Written as Bexagliflozin 20 mgHow we know
- Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy SubjectsStatus unknownPhase 1Newsoara Biopharma Co., Ltd.NCT05369078Written as THR-1442 20mg Single doseHow we know
- An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential HypertensionCompletedPhase 2/3TheracosNCT03514641Written as BexagliflozinHow we know
- Bexagliflozin Drug/Drug Interaction Study With DigoxinCompletedPhase 1TheracosNCT03197324Written as BexagliflozinHow we know
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinCompletedPhase 1TheracosNCT02956044Written as BexagliflozinHow we know
- Bexagliflozin Efficacy and Safety TrialCompletedPhase 3TheracosNCT02558296Written as BexagliflozinHow we know
- Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT01377844Written as EGT0001442How we know
- Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal ImpairmentCompletedPhase 3TheracosNCT02836873Written as BexagliflozinHow we know
- A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT02390050Written as Bexagliflozin tabletsHow we know
- Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesCompletedPhase 3TheracosNCT02715258Written as BexagliflozinHow we know
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedPhase 3TheracosNCT03115112Written as BexagliflozinHow we know
- Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusCompletedPhase 2TheracosNCT01029704Written as EGT0001442How we know
- Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy SubjectsCompletedPhase 1TheracosNCT02820298Written as BexagliflozinHow we know
- Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic ImpairmentCompletedPhase 1TheracosNCT03557658Written as BexagliflozinHow we know
- Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionCompletedPhase 1TheracosNCT03167411Written as BexagliflozinHow we know
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedPhase 3TheracosNCT02769481Written as BexagliflozinHow we know
- Absolute Bioavailability Study With BexagliflozinWithdrawnPhase 1TheracosNCT03417076Written as BexagliflozinHow we know
Given beside what is tested · 1 — Bexagliflozin is usual care or a partner of the new treatment
Codes
What other systems call Bexagliflozin · ClinicalTrials.gg INT001293
- MeSH (NLM) C000705992BexagliflozinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) EY00JF42FVBEXAGLIFLOZINConfirmed FDA, NLM, Wikidata
- Wikidata Q27277423bexagliflozinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169811BexagliflozinOne source FDA
- DrugBank DB12236One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000705992 | Bexagliflozin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | EY00JF42FV | BEXAGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27277423 | bexagliflozin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169811 | Bexagliflozin | One source FDA |
| DrugBank | DB12236 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.